Neurorehabilitation on Upper Limb and on Fatigue in Multiple Sclerosis
Effects of Neurorehabilitation on Upper Limb Performance and on Fatigue in People With Multiple Sclerosis
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- Task Oriented rehabilitation and aerobic training
What it measured
Main measures
Change from Baseline in 9-hole peg test at 2 and 4 months
baseline, then participants were followed for the duration the outpatient treatment protocol, an average of 8 weeks, and at follow up 2 months after the end of the treatment protocol
Disability progressionChange from Baseline in Heart Rate at 2 and 4 months
baseline, then participants were followed for the duration the outpatient treatment protocol, an average of 8 weeks, and at follow up 2 months after the end of the treatment protocol
Who could take part
MS (type not specified) · 18 and over
Show the full criteria
Inclusion criteria
* Diagnosis of Multiple Sclerosis * no relapses in the last three months * Expanded Disability Status Scale (EDSS) ≤ 8;
Exclusion criteria
* subjects with relapses * worsening of the pathology in the last three months * subjects with cognitive and psychiatric disturbances * subjects with cardiovascular disease
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
In Multiple Sclerosis the multiplicity of physical and psychological dysfunctions have been shown to exhibit a number of life-altering problems such as fatigue, limb weakness, alteration of upper extremity fine motor coordination, loss of sensation, spasticity. These problems affect performance of many daily living activities (ADL) such as dressing, bathing, self-care, and writing, thus reducing functional independence and self-rated quality of life. Twenty people with Multiple Sclerosis will receive neurorehabilitation treatment comprising a combination of aerobic training and upper limb task-oriented training. The aim of this pilot crossover study is to evaluate the effects of neurorehabilitation on upper limb performance and on fatigue in People with Multiple Sclerosis.
Loading reviews and guidelines…
History
Started
Nov 2016
Main results due
Dec 2017